Biocon's Bengaluru Facility Gets VAI Status from US FDA after Inspection Dec. 7, 2024, 8:24 p.m. Biocon Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA).The report pertains to Biocon's Active Pharmaceutical Ingredien… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More